Brigatinib vs alectinib in crizotinib-resistant advanced anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALTA-3)
Journal
Future Oncology
Journal Volume
17
Journal Issue
32
Pages
4237-4247
Date Issued
2021
Author(s)
SDGs
Publisher
Future Medicine Ltd.
Type
review